Latest news with #Blindsight
News18
2 days ago
- Business
- News18
Neuralink Recipient Writes Her Name Using Her Thoughts, Elon Musk Says 'Most People Don't Know'
The post quickly went viral, capturing the attention of social media users worldwide. Even Elon Musk responded, confirming the achievement. A woman has amazed people worldwide by revealing that, for the first time in 20 years, she was able to write her name—using only her thoughts. This remarkable breakthrough was made possible by Elon Musk's company, Neuralink. Audrey Crews, who has a Neuralink implant, posted a picture on X (formerly Twitter) showing her signature on a computer screen. She wrote, 'I tried writing my name for the first time in 20 years. I'm working on it. Lol #Neuralink." The post quickly went viral, capturing the attention of social media users worldwide. Even Elon Musk responded, confirming the achievement and explaining, 'She is controlling her computer just by thinking. Most people don't know this can happen." 'This made me cry," said one. 'This technology will change humanity forever," wrote another. Neuralink is also working on a new brain chip called Blindsight. This chip could help blind people see again, and even give them better-than-normal vision. So far, the chip has been tested only in monkeys, but the company hopes to start selling it by 2030. They also plan to earn over a billion dollars a year from different brain implants by 2031. Neuralink's main goal is to create devices that connect directly to the brain. They want to help paralyzed people move, help blind people see, and change how people use technology by linking their minds to computers. view comments First Published: July 28, 2025, 13:03 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Hindustan Times
2 days ago
- Business
- Hindustan Times
Elon Musk reacts as Neuralink recipient writes her name using only thoughts after 20 years: 'This is possible'
A woman has drawn widespread attention online after sharing an extraordinary milestone — signing her name for the first time in 20 years, using only her thoughts. The breakthrough, credited to Elon Musk's company Neuralink, has left social media users amazed. A Neuralink recipient signed her name after 20 years using only her thoughts; Elon Musk reacted. (Also read: 'Doctor dismissed it, Grok didn't': Elon Musk backs Nikita Bier's viral diagnosis post) A historic moment, shared on X Audrey Crews, a Neuralink recipient, posted a photo on X (formerly Twitter) showing her handwritten signature displayed on a laptop caption read, 'I tried writing my name for the first time in 20 years. I'm working on it. Lol #Neuralink.' Quoting her post, another X user wrote, 'Neuralink recipient writes her name for the first time in 20 years telepathically.' Responding to that, Neuralink founder Elon Musk confirmed the achievement, adding, 'She is controlling her computer just by thinking. Most people don't realise this is possible.' Check out the post here: Musk's reply to the post has since garnered nearly 11 million views, drawing attention. One user commented, 'This is the most exciting thing I've seen all year.' Another wrote, 'This technology will change humanity forever.' A third user simply said, 'This made me cry.' Neuralink's vision: Blindsight and beyond According to a recent Bloomberg report, Neuralink is currently developing a brain chip called Blindsight, which aims to restore vision to the blind and potentially provide what they describe as "superhuman vision". While the technology has only been tested in monkeys so far, the company has ambitious plans for its rollout. Bloomberg also reported that Neuralink aims to launch Blindsight commercially by 2030. By 2031, the company hopes to be generating over $1 billion annually in revenue through three distinct types of brain implants. What is Neuralink? As per the company's official description, Neuralink is focused on building devices that allow a bi-directional interface with the brain. Their mission is to "restore movement to the paralysed, restore sight to the blind, and revolutionise how humans interact with their digital world."
Time of India
6 days ago
- Business
- Time of India
Neuralink targets $1 billion revenue by 2031, Bloomberg News reports
Bengaluru: Elon Musk 's brain implant company Neuralink aims to implant its chips in 20,000 people a year, and generate at least $1 billion in annual revenue by 2031, Bloomberg News reported on Wednesday, citing investor documents. The company aims to operate five large clinics within six years and offer three versions of its brain implant, including Telepathy for communication between the brain and machines, Blindsight for restoring vision, and Deep for treating tremors and Parkinson's disease, according to the report. Neuralink did not immediately respond to a Reuters request for comment. The company expects regulatory approval for its Telepathy device by 2029, with plans to perform 2,000 surgeries annually and generate $100 million in revenue, the report said. By 2030, Neuralink anticipates launching Blindsight, expanding surgeries to 10,000 per year and generating over $500 million in revenue. Neuralink, founded in 2016, has raised about $1.3 billion from investors and is valued at roughly $9 billion, the report said, citing PitchBook. The company received the U.S. Food and Drug Administration's "breakthrough" tag for its speech restoration device in May. It had received the same tag for its vision-restoring device last year. Neuralink raised $650 million in its latest funding round last month as its brain implant enters clinical trials . It began human trials in 2024 after resolving safety concerns flagged by the FDA, which had initially rejected Neuralink's application in 2022.
The Hindu
6 days ago
- Business
- The Hindu
Neuralink targets $1 billion revenue by 2031: Report
Elon Musk's brain implant company Neuralink aims to implant its chips in 20,000 people a year, and generate at least $1 billion in annual revenue by 2031, Bloomberg News reported on Wednesday, citing investor documents. The company aims to operate five large clinics within six years and offer three versions of its brain implant, including Telepathy for communication between the brain and machines, Blindsight for restoring vision, and Deep for treating tremors and Parkinson's disease, according to the report. Neuralink did not immediately respond to a Reuters request for comment. The company expects regulatory approval for its Telepathy device by 2029, with plans to perform 2,000 surgeries annually and generate $100 million in revenue, the report said. By 2030, Neuralink anticipates launching Blindsight, expanding surgeries to 10,000 per year and generating over $500 million in revenue. Neuralink, founded in 2016, has raised about $1.3 billion from investors and is valued at roughly $9 billion, the report said, citing PitchBook. The company received the U.S. Food and Drug Administration's "breakthrough" tag for its speech restoration device in May. It had received the same tag for its vision-restoring device last year. Neuralink raised $650 million in its latest funding round last month as its brain implant enters clinical trials. It began human trials in 2024 after resolving safety concerns flagged by the FDA, which had initially rejected Neuralink's application in 2022. According to Neuralink, five patients with severe paralysis are currently using its device to control digital and physical tools with their thoughts.
Business Times
7 days ago
- Business
- Business Times
Neuralink sees US$1 billion of revenue by 2031 in vast expansion
[BOSTON] Elon Musk's brain implant company Neuralink expects to put its chips in 20,000 people a year by 2031, generating at least US$1 billion in annual revenue, in a major ramp-up of its work to treat disease and gain unprecedented access to the human mind, according to documents reviewed by Bloomberg. Within six years, the company also plans to have about five large clinics in operation, with at least three versions of its device available, according to a recent presentation shown to investors. One version, Telepathy, is for enabling communication between the brain and machines; another, Blindsight, is aimed at giving vision to blind people; and a third, Deep, would treat tremors and Parkinson's disease. The financial projections, as well as the company's work in patients with tremors and Parkinson's, have not been previously publicly reported. Representatives for Musk and Neuralink did not immediately respond to a request for comment. The company's stated goals show the enormous scale of Musk's vision for Neuralink and the ambitious timeline on which he seeks to operate. Fewer than 10 people are publicly known to have Neuralink brain devices so far as part of clinical trials, and no patients have them to restore vision or treat Parkinson's. By 2029, the company expects to gain regulatory approval in the US for its Telepathy device, and it hopes to perform 2,000 surgeries a year and generate at least US$100 million in annual revenue, according to the documents. Then by 2030, Neuralink sees the launch of its sight-restoring chip Blindsight, expanding to 10,000 surgeries a year and bringing in over US$500 million. The figures assume 'a conservative reimbursement of US$50k per surgery', the documents show. BT in your inbox Start and end each day with the latest news stories and analyses delivered straight to your inbox. Sign Up Sign Up Neuralink has raised US$1.3 billion from investors and is now valued at US$9 billion, according to PitchBook. Brain-computer interface companies such as Neuralink have attracted significant attention and investment in recent years for potential medical applications. No devices are approved by US regulators for permanent use in humans, as companies are still working on gathering data on safety and effectiveness. Musk has hit a number of milestones with Neuralink, though he is also known for overstating how quickly he will be able to reach technological achievements. For example, in 2015, Musk said that Tesla cars would be able to drive themselves within three years. He moved the timeline back several times and finally launched Robotaxis for testing last month. As part of clinical trials, paralysed patients have used Neuralink devices to control computers, allowing them to browse the internet, play games, and edit videos. The company has also been testing its vision implant in monkeys. Several other brain implant companies are building and testing devices to stimulate or read data from the brain. No brain-computer interfaces are approved commercially for permanent implantation by the US Food and Drug Administration. BLOOMBERG
